Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?
Abstract Aim To assess whether serum thymidine kinase 1 (STK1p), CEA and CA19.9 can be used as prognostic biomarkers in the primary tumor location (PTL) of colorectal carcinoma (CRC). Additional clinical factors of TNM stage, pathological grade, age and sex were also included. Methods STK1p was dete...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2023-02-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-023-00614-5 |
| _version_ | 1827983793630216192 |
|---|---|
| author | Yujing Fang Sven Skog Qingjian Ou Zhiheng Chen Senbo Liu Ailian Hei Jin Li Ji Zhou Ellen He Desen Wan |
| author_facet | Yujing Fang Sven Skog Qingjian Ou Zhiheng Chen Senbo Liu Ailian Hei Jin Li Ji Zhou Ellen He Desen Wan |
| author_sort | Yujing Fang |
| collection | DOAJ |
| description | Abstract Aim To assess whether serum thymidine kinase 1 (STK1p), CEA and CA19.9 can be used as prognostic biomarkers in the primary tumor location (PTL) of colorectal carcinoma (CRC). Additional clinical factors of TNM stage, pathological grade, age and sex were also included. Methods STK1p was determined by an ECL-dot-blot assay, and CEA/CA19.9 was determined by an automatic electrochemiluminescence analyzer in a retrospective presurgery of right-colon carcinoma (R-CC, n = 90), left-colon carcinoma (L-CC, n = 128) and rectal carcinoma (RC, n = 270). Prognostic factors were evaluated by COX and overall survival (OS). Results The multivariate-COX and OS in relation to the prognostic factors of PTL in CRC were different and complex. An elevated STK1p value was significantly associated with poor OS in RC (P = 0.002) and L-CC (P = 0.037) but not in R-CC (P > 0.05). Elevated CEA (P≈.000) and CA19.9 (P≈.000) were significantly associated with poor OS in RC but not in L-CC and R-CC. Multivariate-COX showed that STK1p (P = 0.02, HR = 1.779, 95%CI 1.30–7.582), CEA (P = 0.001, HR = 2.052, 95%CI 1.320–3.189), CA19.9 (P≈.000, HR = 2.574, 95%CI 1.592–4.162) and TNM-stage (P≈.000, HR = 2.368, 95%CI 1.518–3.694) were independent prognostic factors in RC, while TNM-stage was an independent prognostic factor only in R-CC (P = 0.011, HR = 3.139, 95% CI 1.30–7.582) and L-CC (P≈.000, HR = 4.168, 95%CI 1.980–8.852). Moreover, elevated STK1p was significantly more sensitive (P < .001) for predicting mortality than CEA and CA19.9. No correlation was found between STK1p, CEA or AFP. Conclusion Combining TNM stage and suitable biomarkers, STK1p provides further reliable information on the survival of PTL of CRC. |
| first_indexed | 2024-04-09T22:50:30Z |
| format | Article |
| id | doaj.art-7d0bacc0386448b8808b600af833b466 |
| institution | Directory Open Access Journal |
| issn | 2730-6011 |
| language | English |
| last_indexed | 2024-04-09T22:50:30Z |
| publishDate | 2023-02-01 |
| publisher | Springer |
| record_format | Article |
| series | Discover Oncology |
| spelling | doaj.art-7d0bacc0386448b8808b600af833b4662023-03-22T11:39:27ZengSpringerDiscover Oncology2730-60112023-02-0114111710.1007/s12672-023-00614-5Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas?Yujing Fang0Sven Skog1Qingjian Ou2Zhiheng Chen3Senbo Liu4Ailian Hei5Jin Li6Ji Zhou7Ellen He8Desen Wan9Department of Colorectal Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yassin University Cancer CentreDepartment of Medicine, Shenzhen Ellen-Sven Precision Medicine InstituteDepartment of Colorectal Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yassin University Cancer CentreManagement Centre, Third Xiangyan Hospital, Central South UniversityDepartment of Medicine, Shenzhen Ellen-Sven Precision Medicine InstituteDepartment of Medicine, Shenzhen Ellen-Sven Precision Medicine InstituteDepartment of Medicine, Shenzhen Ellen-Sven Precision Medicine InstituteDepartment of Medicine, Shenzhen Ellen-Sven Precision Medicine InstituteDepartment of Medicine, Shenzhen Ellen-Sven Precision Medicine InstituteDepartment of Colorectal Surgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Sun Yassin University Cancer CentreAbstract Aim To assess whether serum thymidine kinase 1 (STK1p), CEA and CA19.9 can be used as prognostic biomarkers in the primary tumor location (PTL) of colorectal carcinoma (CRC). Additional clinical factors of TNM stage, pathological grade, age and sex were also included. Methods STK1p was determined by an ECL-dot-blot assay, and CEA/CA19.9 was determined by an automatic electrochemiluminescence analyzer in a retrospective presurgery of right-colon carcinoma (R-CC, n = 90), left-colon carcinoma (L-CC, n = 128) and rectal carcinoma (RC, n = 270). Prognostic factors were evaluated by COX and overall survival (OS). Results The multivariate-COX and OS in relation to the prognostic factors of PTL in CRC were different and complex. An elevated STK1p value was significantly associated with poor OS in RC (P = 0.002) and L-CC (P = 0.037) but not in R-CC (P > 0.05). Elevated CEA (P≈.000) and CA19.9 (P≈.000) were significantly associated with poor OS in RC but not in L-CC and R-CC. Multivariate-COX showed that STK1p (P = 0.02, HR = 1.779, 95%CI 1.30–7.582), CEA (P = 0.001, HR = 2.052, 95%CI 1.320–3.189), CA19.9 (P≈.000, HR = 2.574, 95%CI 1.592–4.162) and TNM-stage (P≈.000, HR = 2.368, 95%CI 1.518–3.694) were independent prognostic factors in RC, while TNM-stage was an independent prognostic factor only in R-CC (P = 0.011, HR = 3.139, 95% CI 1.30–7.582) and L-CC (P≈.000, HR = 4.168, 95%CI 1.980–8.852). Moreover, elevated STK1p was significantly more sensitive (P < .001) for predicting mortality than CEA and CA19.9. No correlation was found between STK1p, CEA or AFP. Conclusion Combining TNM stage and suitable biomarkers, STK1p provides further reliable information on the survival of PTL of CRC.https://doi.org/10.1007/s12672-023-00614-5Serum thymidine kinase 1 protein concentration (STK1p)CEACA19.9Colorectal carcinoma (CRC)Left colon carcinoma (L-CC)Right colon carcinoma (R-CC) |
| spellingShingle | Yujing Fang Sven Skog Qingjian Ou Zhiheng Chen Senbo Liu Ailian Hei Jin Li Ji Zhou Ellen He Desen Wan Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas? Discover Oncology Serum thymidine kinase 1 protein concentration (STK1p) CEA CA19.9 Colorectal carcinoma (CRC) Left colon carcinoma (L-CC) Right colon carcinoma (R-CC) |
| title | Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas? |
| title_full | Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas? |
| title_fullStr | Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas? |
| title_full_unstemmed | Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas? |
| title_short | Is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas? |
| title_sort | is serum thymidine kinase 1 a prognostic biomarker in primary tumor location of colorectal carcinomas |
| topic | Serum thymidine kinase 1 protein concentration (STK1p) CEA CA19.9 Colorectal carcinoma (CRC) Left colon carcinoma (L-CC) Right colon carcinoma (R-CC) |
| url | https://doi.org/10.1007/s12672-023-00614-5 |
| work_keys_str_mv | AT yujingfang isserumthymidinekinase1aprognosticbiomarkerinprimarytumorlocationofcolorectalcarcinomas AT svenskog isserumthymidinekinase1aprognosticbiomarkerinprimarytumorlocationofcolorectalcarcinomas AT qingjianou isserumthymidinekinase1aprognosticbiomarkerinprimarytumorlocationofcolorectalcarcinomas AT zhihengchen isserumthymidinekinase1aprognosticbiomarkerinprimarytumorlocationofcolorectalcarcinomas AT senboliu isserumthymidinekinase1aprognosticbiomarkerinprimarytumorlocationofcolorectalcarcinomas AT ailianhei isserumthymidinekinase1aprognosticbiomarkerinprimarytumorlocationofcolorectalcarcinomas AT jinli isserumthymidinekinase1aprognosticbiomarkerinprimarytumorlocationofcolorectalcarcinomas AT jizhou isserumthymidinekinase1aprognosticbiomarkerinprimarytumorlocationofcolorectalcarcinomas AT ellenhe isserumthymidinekinase1aprognosticbiomarkerinprimarytumorlocationofcolorectalcarcinomas AT desenwan isserumthymidinekinase1aprognosticbiomarkerinprimarytumorlocationofcolorectalcarcinomas |